For: | Murugan NJ, Voutsadakis IA. Proteasome regulators in pancreatic cancer. World J Gastrointest Oncol 2022; 14(1): 38-54 [PMID: 35116102 DOI: 10.4251/wjgo.v14.i1.38] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i1/38.htm |
Number | Citing Articles |
1 |
Wattana Leowattana, Pathomthep Leowattana, Tawithep Leowattana. Systemic treatment for advanced pancreatic cancer. World Journal of Gastrointestinal Oncology 2023; 15(10): 1691-1705 doi: 10.4251/wjgo.v15.i10.1691
Abstract(184) |
Core Tip(197) |
Full Article(HTML)(956)
|
Full Article with Cover (PDF)-3584K(40)
|
Full Article (Word)-2100K(21)
|
Audio-323K(2)
|
Peer-Review Report-245K(23)
|
Answering Reviewers-77K(23)
|
Full Article (PDF)-3383K(82)
|
Full Article (XML)-303K(23)
|
Times Cited (1)
|
Total Visits (2172)
|
Open
|
2 |
Franz Sellner, Sabine Thalhammer, Martin Klimpfinger. Isolated Pancreatic Metastases of Renal Cell Cancer: Genetics and Epigenetics of an Unusual Tumour Entity. Cancers 2022; 14(6): 1539 doi: 10.3390/cancers14061539
|
3 |
Mariia Ivanova, Luca Bottiglieri, Elham Sajjadi, Konstantinos Venetis, Nicola Fusco. Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances. Genes 2023; 14(2): 376 doi: 10.3390/genes14020376
|
4 |
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk, Rosa Angela Cardone. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Cancers 2022; 14(10): 2486 doi: 10.3390/cancers14102486
|